About Dr. G Ranga Raman
Dr. G Ranga Raman is a Senior Consultant Medical Oncologist with over 13 years of clinical experience, recognised as one of the leading Medical Oncologist specialists in Nellore, India. He is highly regarded for his expertise in immuno-oncology, gastrointestinal oncology, breast oncology and head & neck oncology, and is internationally trained — Hematology Fellowship at Royal Adelaide Hospital (RAH), Australia.
- 13+ years of clinical experience in medical oncology
- 4.5/5 rating on Justdial
- Hematology Fellowship — Royal Adelaide Hospital (RAH), Australia, 2015
- MRCP (SCE) certified
- Member — ESMO, ASCO and ESDO
- Multilingual practitioner — English, Hindi, Telugu
Qualifications & Credentials
Medical Degrees
- MBBS — Prestigious medical college, India. Specific institution and year — Information not publicly available.
- MD (Internal Medicine) — Prestigious medical college, India. Specific institution and year — Information not publicly available.
- DM / MCh (Medical Oncology) — Nizam's Institute of Medical Sciences (NIMS), Hyderabad, Telangana, India
Fellowships & Special Training
- Hematology Fellowship — Royal Adelaide Hospital (RAH), Adelaide, Australia, 2015
- MRCP (SCE) — Specialty Certificate Examination, UK
- Specialised training in Immuno-Oncology
- Specialised training in Gastrointestinal (GI) Oncology
- Specialised training in Breast Oncology
- Specialised training in Head and Neck Oncology
- Specialised training in Targeted Therapy and Chemotherapy
- Specialised training in Pediatric Oncology (CML AYA cohort)
- Specialised training in Hemato-Oncology (Lymphoma, CML)
Certifications & Accreditations
- Andhra Pradesh Medical Council Registration
- DM / MCh (Medical Oncology) — NIMS, Hyderabad (Recognised Specialist Qualification)
- MRCP (SCE) — Royal College of Physicians, UK
- Member — European Society for Medical Oncology (ESMO)
- Member — American Society of Clinical Oncology (ASCO)
- Member — European Society of Digestive Oncology (ESDO)
- Active Member — ISCCP and IMA
Areas of Expertise
Major Conditions Treated
- Breast Cancer
- Triple Negative Breast Cancer
- Lung Cancer
- Stomach (Gastric) Cancer
- Colon & Colorectal Cancer
- Pancreatic Cancer
- Liver Cancer
- Head and Neck Cancers
- Oral Cancer
- Cervical Cancer
- Ovarian Cancer
- Prostate Cancer
- Kidney (Renal) Cancer
- Bladder Cancer
- Skin Cancer
- Chronic Myeloid Leukemia (CML)
- Pediatric CML
- Lymphoma (B-NHL)
- Multiple Myeloma
- Sarcomas
Sub-specialties
- Immuno-Oncology & Targeted Therapy: Immune checkpoint inhibitors, targeted therapy and chemotherapy for solid tumours — sought after as a leading medical oncologist in Nellore, India for systemic cancer therapy.
- Gastrointestinal & Breast Oncology: GI, breast and head & neck cancer management; NLR kinetics in TNBC research — relevant for international patients researching the best medical oncologist doctor in India.
- Hemato-Oncology & Pediatric CML: CML, B-NHL lymphoma management with rituximab-based protocols, plus pediatric CML AYA cohort.
Advanced Procedures & Treatments
- Chemotherapy (Standard, High-Dose, Adjuvant, Neoadjuvant)
- Targeted Therapy (Imatinib, etc.)
- Immunotherapy (Checkpoint Inhibitors)
- Hormone Therapy
- Bone Marrow Aspiration & Biopsy
- Lumbar Puncture & Intrathecal Chemotherapy
- Cytogenetic and Molecular Response Monitoring
- Rituximab-Based Lymphoma Protocols
- NLR (Neutrophil-Lymphocyte Ratio) Prognostic Assessment
- Multidisciplinary Tumour Board Participation
- Cancer Pain Management
- Cervical Cancer Screening Programs
- Breast Cancer Screening Awareness Programs
List of Disease and Treatment for which Dr. G Ranga Raman can be consulted
Professional Experience
Current Affiliation
- Medicover Hospitals / Medicover Cancer Institute, NH-5, Chinthareddypalem Cross Road, Alahari Nagar, Chintareddy Palem, Nellore 524002 / 524003, Andhra Pradesh, India — Senior Consultant Medical Oncologist (Present)
- HCG Curie Cancer Center, Affiliated Practice, India — Consultant Medical Oncologist (Present)
Past Affiliations
- BIACRI (Basavatarakam Indo American Cancer Hospital and Research Institute), India — Junior Consultant, Medical Oncology (2012)
- Royal Adelaide Hospital (RAH), Adelaide, Australia — Hematology Fellow (2015)
- Pradhama Hospital, India — Worked during COVID epidemics (Past)
- Nizam's Institute of Medical Sciences (NIMS), Hyderabad, Telangana, India — DM / MCh (Medical Oncology) Trainee (Past)
Academic & Research Roles
- Active researcher with multiple publications in Journal of Clinical Oncology and Annals of Oncology
- Active member of European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO) and European Society of Digestive Oncology (ESDO)
- Active member in ISCCP and IMA
- Conducted many camps and guest lectures in rural and semi-urban areas for cancer awareness among women
- Conducted Adolescent Education Programs
- Conducted Cervical and Breast Cancer Screening Programs
Key Achievements
- 13+ years of clinical experience in medical oncology
- Hematology Fellowship — Royal Adelaide Hospital (RAH), Australia, 2015
- MRCP (SCE) certified
- 4.5/5 rating on Justdial
- Multiple international publications in Journal of Clinical Oncology and Annals of Oncology (2013-2019)
- Worked at Pradhama hospital during COVID epidemic
- Senior Consultant role at Medicover Cancer Institute, Nellore — a leading multi-speciality cancer hospital
Awards & Recognitions
National & International Awards
- Hematology Fellowship — Royal Adelaide Hospital (RAH), Adelaide, Australia, 2015
- MRCP (SCE) certified — Royal College of Physicians, UK
- 4.5/5 rating on Justdial
- Information on additional national / international awards — Information not publicly available.
Professional Memberships
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
- European Society of Digestive Oncology (ESDO)
- Indian Society of Clinical Cancer Practitioners (ISCCP)
- Indian Medical Association (IMA)
- Andhra Pradesh Medical Council
Research & Publications
Published Papers (Selected)
- Outcomes in pediatric CML in a developing country — Beyond the disease biology. Journal of Clinical Oncology 32, 2014, no. 15_suppl e21005.
- Prognostic significance of NLR kinetics in operable triple negative breast cancer. Journal of Clinical Oncology 37, 2019, no. 15_suppl e14201.
- Cytogenetic and molecular response rates in AYA CML CP patients on imatinib based on the baseline BMI. Annals of Oncology, Volume 27, Issue suppl_9, December 2016, mdw586.009.
- Is rituximab-based chemotherapy a standard practice in the treatment of B-NHLs in the developing world. Journal of Clinical Oncology 31, 2013_suppl e19533.
- Secondary malignancies in CML patients: a retrospective analysis from tertiary care center in India. Annals of Oncology, Volume 26, Issue suppl_9, 1 December 2015, Page ix92.
Ongoing Research & Clinical Interests
- Immuno-oncology and targeted therapy
- Gastrointestinal (GI) oncology
- Breast oncology and triple negative breast cancer
- Head and neck oncology
- Chronic myeloid leukemia (CML) and pediatric CML
- B-NHL lymphoma management
- NLR kinetics as prognostic marker
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Medical Oncology Consultation | ₹600 – ₹1,500 | $8 – $18 |
| Chemotherapy (per cycle) | ₹40,000 – ₹2,50,000 | $480 – $3,000 |
| Targeted Therapy / Imatinib (Annual) | ₹1,20,000 – ₹6,00,000 | $1,440 – $7,200 |
| Immunotherapy (per cycle) | ₹2,00,000 – ₹8,00,000 | $2,400 – $9,600 |
| Hormone Therapy (Annual) | ₹40,000 – ₹2,00,000 | $480 – $2,400 |
| Bone Marrow Biopsy | ₹15,000 – ₹40,000 | $180 – $480 |
| Cytogenetic / Molecular Testing | ₹15,000 – ₹70,000 | $180 – $840 |
| Breast Cancer Treatment Package | ₹4,00,000 – ₹14,00,000 | $4,800 – $16,800 |
| GI Cancer Treatment Package | ₹4,50,000 – ₹15,00,000 | $5,400 – $18,000 |
| Head & Neck Cancer Treatment Package | ₹4,00,000 – ₹13,00,000 | $4,800 – $15,600 |
| CML / Lymphoma Treatment Package | ₹4,00,000 – ₹16,00,000 | $4,800 – $19,200 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. G Ranga Raman use in Medical Oncologist treatment?
Dr. G Ranga Raman employs the latest evidence-based tools, minimally invasive techniques and modern protocols relevant to Medical Oncologist. Virtual consultations and remote second opinions are also available to international patients. Contact Cancer Rounds for a detailed technology overview specific to your case.
2. What conditions does Dr. G Ranga Raman specialize in treating?
As a leading Medical Oncologist specialist in Nellore, India, Dr. G Ranga Raman treats a broad spectrum of conditions in this field — from common presentations to complex cases. Patients from across India and abroad seek treatment for conditions requiring expert Medical Oncologist care, making Dr. G Ranga Raman one of the best Medical Oncologist doctors in India.
3. How do I book an appointment with Dr. G Ranga Raman?
Appointments with Dr. G Ranga Raman can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. G Ranga Raman?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. G Ranga Raman, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. G Ranga Raman offer second opinions for Medical Oncologist cases?
Yes. Second opinion consultations with Dr. G Ranga Raman can be arranged via Cancer Rounds for patients seeking expert review of their treatment plan from a Medical Oncologist specialist in Nellore, India.










